- Home
- LIXT vs ATPC Comparison
LIXT vs ATPC Comparison
Compare LIXT & ATPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LIXT
- ATPC
- Stock Information
- Founded
- LIXT 2005
- ATPC 2016
- Country
- LIXT United States
- ATPC Malaysia
- Employees
- LIXT N/A
- ATPC N/A
- Industry
- LIXT Biotechnology: Pharmaceutical Preparations
- ATPC Medical/Nursing Services
- Sector
- LIXT Health Care
- ATPC Health Care
- Exchange
- LIXT Nasdaq
- ATPC Nasdaq
- Market Cap
- LIXT 6.3M
- ATPC 6.5M
- IPO Year
- LIXT N/A
- ATPC N/A
- Fundamental
- Price
- LIXT $1.27
- ATPC $0.94
- Analyst Decision
- LIXT
- ATPC
- Analyst Count
- LIXT 0
- ATPC 0
- Target Price
- LIXT N/A
- ATPC N/A
- AVG Volume (30 Days)
- LIXT 155.3K
- ATPC 135.2K
- Earning Date
- LIXT 03-18-2025
- ATPC 02-28-2025
- Dividend Yield
- LIXT N/A
- ATPC N/A
- EPS Growth
- LIXT N/A
- ATPC N/A
- EPS
- LIXT N/A
- ATPC N/A
- Revenue
- LIXT N/A
- ATPC $1,354,042.00
- Revenue This Year
- LIXT N/A
- ATPC N/A
- Revenue Next Year
- LIXT N/A
- ATPC N/A
- P/E Ratio
- LIXT N/A
- ATPC N/A
- Revenue Growth
- LIXT N/A
- ATPC N/A
- 52 Week Low
- LIXT $1.25
- ATPC $0.90
- 52 Week High
- LIXT $4.40
- ATPC $8.40
- Technical
- Relative Strength Index (RSI)
- LIXT 28.82
- ATPC 35.57
- Support Level
- LIXT $1.35
- ATPC $0.90
- Resistance Level
- LIXT $3.00
- ATPC $0.97
- Average True Range (ATR)
- LIXT 0.26
- ATPC 0.09
- MACD
- LIXT -0.13
- ATPC -0.03
- Stochastic Oscillator
- LIXT 1.15
- ATPC 7.06
About LIXT Lixte Biotechnology Holdings Inc.
Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.
About ATPC Agape ATP Corporation
Agape ATP Corp through its subsidiaries is engaged in providing health and wellness products and health solution advisory services. The principal activities of the company are to supply high-quality health and wellness products, including a supplement to assist in cell metabolism, detoxification, blood circulation, anti-aging and products designed to improve the overall health system in a body. Its product portfolio includes ATP1s Survivor Select, ATP2 Energized Mineral Concentrate, ATP3 Ionized Cal-Mag, ATP4 Omega Blend, AGN-Vege Fruit Fiber and Others.